Air Products (APD)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-11-04
NYSEMaterialsChemicals - SpecialtySnapshot 2026-11-04
Research Workspace
Put APD beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Materials: fringe margins under pressure (0q confirmed)
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Full-year adjusted EPS of $13.12 in fiscal 2026: Comparison needs review.
View ThesisRevenue is growing steadily — about 5% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 34%, softest on free-cash-flow margins.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look high — the market is pricing in about 28% growth a year, above the roughly 7% analysts expect, leaving little room for error.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskAPD's core industrial gas growth must keep compounding to justify the price. Revenue grew 9% year over year in the latest quarter. The company beat its earnings estimate by 4.6%. It trades at 24 times earnings versus a 16 times peer median. The market is pricing in more growth than we forecast. The primary pillar is under pressure. The thesis comparison is not yet verified. Peer multiples imply a price about 28% below where it trades. The thesis is on watch.
Trailing returns as of 2026-11-04. APD is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 23 analysts currently covering APD (as of Nov 2026).
Based on 9 Wall Street analysts offering 12-month price targets for APD in the last 4 months.
Continue this research
Compare APD with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| APD Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-11-05. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Materials (broad) — fair value, gap to price, and forward P/E.
Compare the value case
Put APD next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Raise full-year adjusted EPS guidance
Official guidance confirms EPS growth and CapEx discipline.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $318.87
The last 12 months of price, then the range of analyst 12-month targets from today’s $318.87.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Advances: Raise full-year adjusted EPS guidance
FY27 outlook beats estimates, supporting EPS growth objective.

Advances: Optimize large project portfolio and focus on core industrial gas growth
New deal aligns with optimizing project portfolio and growth.

Advances: Optimize large project portfolio and focus on core industrial gas growth
Finalizing deal supports focus on core industrial gas growth.

Advances: Optimize large project portfolio and focus on core industrial gas growth
Focus on core industrial gas growth aligns with management's strategy.

Advances: Raise full-year adjusted EPS guidance
S&P's stable outlook supports EPS growth expectations.

Advances: Maintain capital expenditures at $4 billion
Facility expansion supports capital expenditure objectives.
Price target increase reflects positive earnings outlook.